Paroxysmal Atrial Fibrillation in the Course of Acute Pulmonary Embolism: Clinical Significance and Impact on Prognosis
Table 3
Comparison of the baseline laboratory and echocardiographic parameters in patients with sinus rhythm (SR), paroxysmal atrial fibrillation (paroxysmal AF), and permanent atrial fibrillation (permanent AF).
SR (), Me (Q1–Q3) or %
Paroxysmal AF (), Me (Q1–Q3) or %
Permanent AF (), Me (Q1–Q3) or %
value
Biochemical parameters
eGFR, ml/min/1.73 m2
76 (59–93)
63 (51–83)
53 (33–79)
<0.001
Troponin I, ng/ml
0.066 (0.01–0.4)
0.11 (0.046–0.42)
0.036 (0.008–0.34)
0.3
D-dimer, ng/ml
5.6 (3–12.0)
10.6 (3.5–19.9)
11 (4.2–15.1)
0.3
Hemoglobin, g/dl
12.7 (11.4–14)
13.2 (11.4–14.7)
12.6 (10.7–15)
0.58
Echocardiography
LVEF, %
60 (50–60)
55 (50–60)
48 (30–55)
<0.001
LA, cm
3.7 (3.3–4.0)
3.9 (3.6–4.4)
4.4 (4.2–5.1)
<0.001
SPAP, mmHg
47 (37–59)
56 (47–70)
48 (45–59)
0.01
ACT, ms
70 (54–95)
58 (51–65)
65 (55–80)
0.04
RV wall contractility disturbances
58.4%
77.4%
67.9%
0.09
Thrombus in RA/RV
5.2%
10%
14.3%
0.11
Me (Q1–Q3) or %: data presented as a median and interquartile range or a percent of the group value < 0.05; value < 0.01; value < 0.001; value . ACT: acceleration time; GFR: glomerular filtration rate; LA: left atrium; LVEF: left ventricular ejection fraction; SPAP: systolic pulmonary artery pressure; RV: right ventricle.
